PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY PRODUCT • Market segmentation by product • Comparison by product • Consumables - Market size and forecast 2018-2023 • Systems - Market size and forecast 2018-2023 • Market opportunity by product PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • Americas - Market size and forecast 2018-2023 • EMEA - Market size and forecast 2018-2023 • APAC - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 09: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 10: TRENDS • Technological advancements PART 11: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 12: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Abbott • BD • bioMérieux • F. Hoffmann-La Roche • Quidel PART 13: APPENDIX • Research methodology • List of abbreviations   Exhibit 01: Years in consideration Exhibit 02: Global in-vitro diagnostics (IVD) market Exhibit 03: Segments of global in-vitro diagnostics (IVD) market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2018 Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 09: Global market: Year-over-year growth 2019-2023 (%) Exhibit 10: Five forces analysis 2018 Exhibit 11: Five forces analysis 2023 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2018 Exhibit 18: Product - Market share 2018-2023 (%) Exhibit 19: Comparison by product Exhibit 20: Consumables - Market size and forecast 2018-2023 ($ millions) Exhibit 21: Consumables - Year-over-year growth 2019-2023 (%) Exhibit 22: Systems - Market size and forecast 2018-2023 ($ millions) Exhibit 23: Systems - Year-over-year growth 2019-2023 (%) Exhibit 24: Market opportunity by product Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2018-2023 (%) Exhibit 27: Geographic comparison Exhibit 28: Americas - Market size and forecast 2018-2023 ($ millions) Exhibit 29: EMEA - Year-over-year growth 2019-2023 (%) Exhibit 30: Top 3 countries in EMEA Exhibit 31: APAC - Market size and forecast 2018-2023 ($ millions) Exhibit 32: APAC - Year-over-year growth 2019-2023 (%) Exhibit 33: Key leading countries Exhibit 34: Market opportunity Exhibit 35: Decision framework Exhibit 36: Product launches by companies Exhibit 37: Product recalls Exhibit 38: Impact of drivers and challenges Exhibit 39: Vendor landscape Exhibit 40: Landscape disruption Exhibit 41: Vendors covered Exhibit 42: Vendor classification Exhibit 43: Market positioning of vendors Exhibit 44: Abbott - Vendor overview Exhibit 45: Abbott - Business segments Exhibit 46: Abbott - Organizational developments Exhibit 47: Abbott - Geographic focus Exhibit 48: Abbott - Segment focus Exhibit 49: Abbott - Key offerings Exhibit 50: Abbott - Key customers Exhibit 51: BD - Vendor overview Exhibit 52: BD - Business segments Exhibit 53: BD - Organizational developments Exhibit 54: BD - Geographic focus Exhibit 55: BD - Segment focus Exhibit 56: BD - Key offerings Exhibit 57: BD - Key customers Exhibit 58: bioMérieux - Vendor overview Exhibit 59: bioMérieux - Business segments Exhibit 60: bioMérieux - Organizational developments Exhibit 61: bioMérieux - Geographic focus Exhibit 62: bioMérieux - Segment focus Exhibit 63: bioMérieux - Key offerings Exhibit 64: bioMérieux - Key customers Exhibit 65: F. Hoffmann-La Roche - Vendor overview Exhibit 66: F. Hoffmann-La Roche - Business segments Exhibit 67: F. Hoffmann-La Roche - Organizational developments Exhibit 68: F. Hoffmann-La Roche - Geographic focus Exhibit 69: F. Hoffmann-La Roche - Segment focus Exhibit 70: F. Hoffmann-La Roche - Key offerings Exhibit 71: F. Hoffmann-La Roche - Key customers Exhibit 72: Quidel - Vendor overview Exhibit 73: Quidel - Product segments Exhibit 74: Quidel - Organizational developments Exhibit 75: Quidel - Geographic focus Exhibit 76: Quidel - Segment focus Exhibit 77: Quidel - Key offerings Exhibit 78: Quidel - Key customers Exhibit 79: Validation techniques employed for market sizing Exhibit 80: List of abbreviations  

Abbott BD bioMérieux F. Hoffmann-La Roche Quidel